https://orcid.org/0000-0003-0242-5208The vision of our research program is multifaceted. The ultimate goal of our research is to enhance the care of patients with genetic-based arrhythmia disorders through clinical and precision medicine research approaches and to establish potential novel drug targets for therapeutic targeting. Our research aims are as follows:
- To identify novel genetic contributors of arrhythmia syndromes, including atrial fibrillation, sudden death arrhythmias and brady-arrhythmias
- To describe novel cellular physiological mechanisms contributing to arrhythmia syndromes
- To develop experimental models of arrhythmia syndromes to delineate in vivo physiology and/or test novel drug therapies
- To participate in international collaborative studies and clinical descriptive studies of arrhythmia cohorts
- To translate genetic discoveries to elucidate the physiological mechanisms of abnormal cardiac rhythms in humans
- To apply genetic information in the care of patients with inherited heart rhythm disorders